• Subscribe
    • Sign up for updates about the journal.
  • Sign in
  • Register
Exploration of Immunology
  • About
    • About the Journal
    • Editorial Board
    • Editorial Policies
    • Newsletter
    • Contact Us
  • Articles
    • Current Issue
    • Archives
  • Special Issue
    • All Special Issues
    • Guest Editor Guidelines
  • For Authors
    • Author Instructions
    • Editorial Process
    • Peer Review
    • Article Processing Charge
    • Submit a Manuscript
  • For Reviewers
    • Peer Review Guidelines
    • Reviewer Acknowledgment
    • To Be a Reviewer
  • Focus
  • Home
  • Exploration of Immunology
  • Special Issues
  • Special Issue Topic

    Autoantibodies Associated to Thrombosis and Hemostasis

    Submission Deadline: February 28, 2023

    Guest Editor

    Dr. Jean Amiral E-Mail

    Scientific Director (SH-Consulting, Franconville, France) and consultant (HYPHEN BioMed, France and Sysmex Corp., Japan), Franconville, France

    Research Keywords: hemostasis, coagulation, thrombosis, fibrinolysis, autoantibodies, pathogenicity, laboratory methods, molecular mechanisms


    About the Special Issue

    These past decades occurrence of some life threatening complications, often irresponsive to the drugs indicated for treating the clinical symptoms, have been reported. Presence of pathogenic autoantibodies, targeted to hemostasis proteins or to their complexes with non-self-components like drugs or infectious products, has been evidenced in many cases. If now these allo-immune or auto-immune complications are progressively better diagnosed, their development conditions still remain unclear. Possible factors can concern individual biological sensitivity or predisposal, but the accidental presentation of a self-component in an unusual way or complexed with an external product can be a leading risk. An open question remains on why in apparently identical situations only rare patients develop the pathogenic antibodies, and why, when present, these antibodies remain asymptomatic in many cases or conversely they provoke severe and deleterious pathologies. The experience from some extensively studied induced autoimmune diseases helps to better document this domain. In this issue, we focus on autoantibodies targeted to hemostasis proteins, and which can lead to critical bleeding episodes or thrombo-embolic manifestations. Diseases are strongly depending on how the autoantibody interferes with the targeted protein function. They can be targeted to body’s cells or tissues deviating then the immune response, which then becomes harmful. The most known, investigated and documented diseases concern anti-phospholipid antibodies and lupus anticoagulant, with autoantibodies mainly targeted to β2-Glyco-Protein 1, Prothrombin, Annexin V or to their complexes with phospholipids, or heparin induced thrombocytopenia, with a high incidence of associated thrombosis, and which is induced by an heparin dependent antibody targeted to Platelet Factor 4 complexed with heparin, or to the chemokine itself. However, many other very rare autoantibody induced thrombotic complications have been reported for antibodies to Protein S, Thrombomodulin, Protein Z, antithrombin, or to other hemostasis proteins, whilst other autoantibodies are associated to severe bleeding like those to factor VIII, vWF, Factor V, Factor XIII, list which is not exhaustive. This is what we would like to describe and synthesize in this special issue, by presenting the latest updates and understandings. The major objectives are to review: i) the various autoimmune complications generating thrombotic or bleeding episodes; ii) the laboratory diagnostic tools available; iii) the mechanisms which can lead to the generation of autoantibodies, and when present, how they become pathogenic; iv) the available therapeutic approaches; v) cases and experience report. We are please to call for contributions in this field, and we invite you to submit your contributions, which will follow a pier review process, and when approved will be published in that special issue of Exploration of Immunology.

    Keywords: autoantibodies, hemostasis proteins, autoimmune complications, thrombotic, bleeding

    Call for Papers

    Published Articles

    • Submit a Manuscript
    • Aims and Scope
    • Editorial Board
    • Author Instructions
    • Ongoing Special Issues
      New insights in cancer immunology: the role of microbiota from immunosurveillance to immunotherapy
      Immunology, Immunopathology and Genomics of SARS-COV-2
      Interplay of Stem Cells and Immunology in Regenerative Medicine
      Cytokines and Skin Diseases
      DNA Sensing in Lung Inflammation
      The Role of Adaptor Proteins in Lymphoid Cell Signaling
      Nanomaterials interaction with chemokines: perspectives for applied immunology
      Old and New Paradigms in Viral Vaccinology
      Autoantibodies Associated to Thrombosis and Hemostasis
      Immunosenescence: Mechanisms and Its Impact
      The Complement System in Health and Disease
      Chronic Inflammation and Autoimmunity
      Bioinformatics, Big Data, AI: Exploring Immunology
      Role of NK cells, Chemokines, and Pyroptosis in Melanoma Development or Treatment
      Immunoregulatory Function of Mesenchymal Stem Cells in Tissue Repair and Regeneration
      The Immune Signature of Microgravity
      Cell Biology and Treatment of Autoimmune Diseases
      Mucosal Immune Cells - Border Protection or Entrance Gate?
      Immunobiology of Dendritic Cells
      Neuroimmunology of Multiple Sclerosis: Exploring New Perspectives
      Physical Activity and Immune System in Chronic Diseases : Mechanisms and Insights
      Immunobiology and Inflammation in the Male Reproductive System
    • Completed Special Issues
      Cross Talk Among Skin Cells and Immune Cells
      Vaccine-induced Immune Responses Against SARS-CoV-2 Infections
      Human Reproduction: Involvement of the Immune System
      Interplay of γδ T cells and Tumor Cells
      The‌ ‌Sepsis‌ ‌induced‌ ‌Immune‌ ‌Conundrum
    • Guest Editor
    • About the Special Issue
    • Call for Papers
    • Published Articles
    • Exploration of Immunology
    • eISSN 2768-6655
    • eijournal@explorationpub.com
    • About the Journal
    • Author Instructions
    • Editorial Board
    • Editorial Policies
    • Editorial Process
    • Peer Review
    • Follow the Journal
    • JOURNALS
    • Exploration of Medicine
    • Exploration of Targeted Anti-tumor Therapy
    • Exploration of Immunology
    • Exploration of Neuroprotective Therapy
    • Exploration of Digestive Diseases
    • Exploration of Neuroscience
    • Exploration of Musculoskeletal Diseases
    • Exploration of Asthma & Allergy
    • Exploration of Drug Science
    • Exploration of Foods and Foodomics
    • Exploration of BioMat-X
    • Exploration of Digital Health Technologies
    • Exploration of Cardiology
    • Exploration of Endocrine and Metabolic Disease
    • ABOUT
    • Company Information
    • Open Access
    • Editorial Policies
    • Peer Review Policy
    • Contact Us
    • FOLLOW
    • Terms of Service Privacy Cookies
Copyright © 2023 Open Exploration Publishing Inc.